Business Insider

Fluidigm to Unveil High-Parameter Tissue Imaging System

SOUTH SAN FRANCISCO, Calif., Oct. 18, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that it will unveil a commercially available system for high-parameter tissue imaging ...
Business Insider

Fluidigm Licenses CFTR Next-Generation Sequencing Assay From Baylor Genetics for Use With the Juno System

SOUTH SAN FRANCISCO, Calif., Aug. 17, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) and Baylor Genetics today announced that they have entered into a licensing agreement to offer a ...
The Scientist

Fluidigm Introduces Advanced Mass Cytometry System

Fluidigm Corporation (NASDAQ:FLDM) today introduced HeliosTM, a CyTOF® platform that enables system-level biology at single-cell resolution, on an accessible, expandable system designed for ...
GEN

Oncomed to Exploit Fluidigm’s Microfluidic Devices in Cancer Stem Cell Research

Collaboration will perform gene-expression analysis of tumors and evaluate changes in cancer stem cells when mAbs are used. OncoMed Pharmaceuticals is tapping Fluidigm’s microfluidic tools for the ...
The Scientist

Content by Fluidigm Corporation

Fluidigm’s New Helios Platform Combines Ease-of-Use Enhancements with Multi-Modal Capabilities for High-Resolution, High-Content Single-Cell Biology. See how the BD FACSDiscover™ A8 Cell Analyzer uses ...
CNN

OU Medicine, University of Oklahoma Health Sciences Center and Oklahoma Medical Research Foundation File for FDA Emergency Use Authorization for COVID-19 Detection Test ...

SOUTH SAN FRANCISCO, Calif., April 23, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive ...